Ramazzini 2018: The Independent Italian Study That Replicated the NTP Cancer Finding at Far Lower Exposure

EMF Research File — The Landmark Studies

Ramazzini 2018: The Independent Italian Study That Replicated the NTP Cancer Finding at Far Lower Exposure

Falcioni L et al., 2018 — Environmental Research — Ramazzini Institute, Italy

“Our findings on carcinogenic effects of RFR [at environmental exposure levels] are consistent with and reinforce the results of the NTP study.” — Falcioni et al., 2018
Study: Report of final results regarding brain and heart tumors in Sprague-Dawley rats exposed from prenatal life until natural death to mobile phone radiofrequency field representative of a 1.8 GHz GSM base station environmental emission
Institution: Ramazzini Institute, Bologna, Italy
Authors: Falcioni L, Bua L, Tibaldi E, Lauriola M, De Angelis L, et al.
Journal: Environmental Research, 2018
Key finding: Schwannoma of the heart in male rats — at exposure levels far below NTP, matching environmental tower emissions
1.8 GHz
Frequency (GSM base station, environmental exposure)
50 V/m
Maximum field strength (environmental level, far below NTP)
Prenatal
Exposure started before birth — lifetime study
2+ yrs
Exposure duration until natural death

Why Independent Replication Changes Everything

In science, a single study — no matter how well designed — is a claim. Two independent studies finding the same result in the same tumor type through different methods is convergence. The Ramazzini replication of the NTP schwannoma finding elevates the result from interesting to significant.

The Ramazzini Institute is one of the most respected independent cancer research organizations in the world. It operates without industry funding and has a 50-year track record of identifying industrial carcinogens through large-scale animal studies. Its participation in this question is not incidental — it specifically designed a study to test the NTP finding using different exposure conditions.

The Critical Difference: Exposure Levels

Schwannoma at environmental exposure levels. The Ramazzini study found statistically significant increases in schwannoma of the heart in male rats — the same tumor type as NTP — at exposure levels corresponding to environmental tower emissions. The NTP used near-field exposure (device-level). The Ramazzini used far-field whole-body exposure at levels simulating the ambient RF-EMF from a cell tower. The schwannoma finding held at both ends of the exposure spectrum.
Prenatal through lifetime exposure. Unlike most animal studies that begin exposure in adult animals, the Ramazzini exposed animals from prenatal life until natural death. This is more relevant to current human exposure patterns — children today are exposed from birth and will accumulate decades of wireless device exposure. The prenatal exposure window may be particularly significant for developmental biological effects.
Consistent with NTP; reinforcing, not replicating exactly. The Ramazzini exposure protocol was deliberately different from NTP’s. The convergence on schwannoma despite different frequencies, different SAR levels, different exposure methods (near-field vs. far-field), and different exposure durations is precisely what makes independent replication scientifically meaningful.
Why “environmental exposure levels” matters: Critics of the NTP study argued that the exposure levels used were higher than typical cell phone use. The Ramazzini study removes this argument for the schwannoma finding: the tumor appeared even at ambient tower-level exposure — the kind of exposure experienced by anyone living near a cell tower or in an urban RF environment, regardless of personal device use.

The Aires Research Connection

The Ramazzini finding is particularly relevant to the Aires research corpus because it establishes that the cancer signal appears at environmental exposure levels — not just device-level exposure. The IFRAN rat study series used Wistar rats exposed to ambient RF-EMF conditions to test whether structural field modulation alters biological response. The Ramazzini result is the reference point for understanding why environmental exposure levels deserve the same rigorous study as near-field device exposure. Explore the Aires research corpus →

Two independent labs. Two countries. Same tumor. One at environmental exposure levels.

The Ramazzini finding means the cancer signal exists at the background RF-EMF of modern life — not just from devices you hold.

Shop Aires Products →

Frequently Asked Questions

What did the Ramazzini 2018 study find about EMF and cancer?

The Ramazzini Institute found significantly increased schwannoma of the heart in male rats exposed to RF-EMF at levels simulating environmental cell tower emissions — far lower than the levels used in the NTP study. This independently replicated the NTP heart schwannoma finding using different exposure conditions, strengthening the overall evidence that RF-EMF at currently prevalent levels may be carcinogenic.

How does the Ramazzini study differ from the NTP study?

The NTP used near-field whole-body exposure at 900 MHz at SAR values up to 6 W/kg, simulating device-level exposure. The Ramazzini used far-field whole-body exposure at 1.8 GHz at environmental power density levels (5–50 V/m), simulating what people experience from ambient cell tower emissions. Both found schwannoma in male rats, making this a genuine independent replication across very different exposure conditions.

Is the Ramazzini Institute credible?

The Ramazzini Institute is one of the world’s most respected independent cancer research organizations, with a 50-year history of identifying industrial carcinogens through long-term animal studies. It identified formaldehyde as a leukemia risk before regulatory agencies acknowledged it. It operates without industry funding and has no commercial interests in RF-EMF safety outcomes.

Do the NTP and Ramazzini studies prove cell phones cause cancer?

They provide strong experimental evidence for RF-EMF carcinogenicity in rats at exposure levels relevant to current human wireless exposure. Whether these findings extrapolate to human cancer outcomes at real-world exposure levels requires epidemiological validation over longer follow-up periods. The studies are consistent with the Hardell long-term human glioma data and together form a converging multi-study signal that regulators are increasingly unable to dismiss.